India Investment News: Monday was very positive for the Indian stock market. The domestic market saw a strong rise and both the Sensex and Nifty closed on the major index green mark. Meanwhile, there has been another good news for India from America.
American Pharma Giant Eli Lily & Co. has announced to invest US $ 1 billion (about Rs 8,879 crore) in India. The company has said that the purpose of this investment is to strengthen its manufacturing and supply chain capabilities in India.
A new center will be built in Hyderabad
Eli Lily Company has informed that it will set up its new center in Hyderabad. The center will serve as the main hub for the company’s manufacturing network across the country and provide high quality technology and innovation services.
The company launched weight loss and diabetes drug ‘Mounjaro’ in India earlier this year, whose global demand is increasing continuously. Experts say that this investment of Eli Lily is being made in mind obesity and the increasing market of diabetes drugs, which can give the company a big benefit in future.
Telangana Chief Minister A.K. Revant Reddy expressed happiness over Eli Lily’s investment, saying, “Lily company’s investment in Hyderabad is proof that the city has become a reliable and emerging center of Global Health Service Innovation.” He said that this investment will not only increase employment opportunities in the state, but will also give a new direction to India’s biotech and pharma industry.
Emphasis on increasing local partnership and production
Elli Lily has reported that it will partner with local pharmaceutical companies in Telangana to increase the production and distribution capacity of drugs. The company says that this will make the medicines related to obesity and diabetes more accessible and economical in India.
Lily International Executive Vice President Patrick Johnson said, “We are taking important steps to increase our manufacturing and medicine supply capacity globally. This investment of $ 1 billion in India is part of this strategy.”
This investment can prove to be a big opportunity for India’s healthcare and pharma sector. Experts believe that companies like Eli Lily confirms the country’s trend towards India, the drug manufacturing capacity of the country, technology infrastructure and global investment attractions.
ALSO READ: Stock market once again became the life of the market for bulish, IT and banking sector, know the reason for this
